Nephrolithiasis: Clinical Trials

35 trials for Nephrolithiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 9 unknown, 4 recruiting, 3 terminated. 35 Phase 3, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 335Completed 15, Unknown 9, Recruiting 4, Terminated 3, Withdrawn 3, Active not recruiting 1
Phase 28Completed 4, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1

Follow Nephrolithiasis: new trials by email Literature Review of Nephrolithiasis trials Research Report on Nephrolithiasis

Trials (filtered) newest first · largest first

All 35 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The GranStone Trial
empagliflozin (Jardiance) 25 mg, Losartan 100 mg - Paraffinoma, Granuloma, Foreign-Body
Phase 2 / Phase 3RecruitingMartin Blomberg Jensen1002026-10-202026-11-10
Trial to Assess the Efficacy of EMPAgliflozin and Personalized Dietary Counseling for Kidney STONE Prevention
Empagliflozin 10 MG, Placebo, Personalized dietary counseling - Kidney Stone, Nephrolithiasis
Phase 3RecruitingInsel Gruppe AG, University Hospital Bern4002026-07-022026-10-23
Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery
spinal analgesia with morphine and bupivacaine, lidocaine infusion - Other Specified Disorders of Kidney and Ureter, Benign Neoplasm of Ureter
Phase 3RecruitingHans Bahlmann2202024-04-092026-02-05
Impact of Forced Diuresis on the Residual Fragment Rate After Flexible Ureteroscopy for Destruction of Kidney Stones With Laser
Furosemide 40 mg - Kidney Stone
Phase 3RecruitingUniversity Hospital, Tours3742024-01-042026-11-09
Flexible Mini Percutaneous Nephrolithotomy Vs Retrograde Intra-renal Surgery
flexible mini percutaneous nephrolithotomy, Retrograde intrarenal surgery - Renal Stone
Phase 2 / Phase 3CompletedAin Shams University1302024-01-012024-10-29
Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1
Encaleret, Standard of Care - Autosomal Dominant Hypocalcemia (ADH)
Phase 3Active not recruitingCalcilytix Therapeutics, Inc., a BridgeBio company672023-01-062026-07-29
Enhanced Versus Extended Preoperative Antibiotic Prophylaxis Regimens for Retrograde Intrarenal Surgery in High Infectious Risk Patients
Enhanced regimen, Extended regimen - Renal Stone
Phase 3UnknownMansoura University2802022-05-012022-11-14
Tamsulosin Assisted Ureteral Access Sheath Insertion
Tamsulosin - Renal Stone, Retrograde Intrarenal Surgery
Phase 3CompletedSengkang General Hospital1102022-03-012026-09-30
Ultra-Mini Versus Standard Percutaneous Nephrolithotomy For Management Of Renal Calculi. A Randomized Controlled Trial.
percutaneous nephrolithotomy, ultra-mini percutaneous nephrolithotomy - Stone, Kidney
Phase 3UnknownAin Shams University602021-02-282021-02-21
Holmium Vs Trilogy Kidney Stones GUY's 1-2
Fragmentation of calculi with 100 W Holmium laser or LithoClast Trilogy EMS and 1.5 mm x 440 mm probe, according to randomization. - Kidney Stone, Kidney Calculi
Phase 3UnknownHospital Regional de Alta Especialidad del Bajio1162020-09-302020-09-22
Effect of Furosemide on ESWL Outcomes for Renal and Ureteral Calculi
Furosemide 40 mg, Conventional Treatment - Urolithiasis, Nephrolithiasis
Phase 3UnknownShiraz University of Medical Sciences5002020-07-012022-03-08
Perioperative Pregabalin in Ureteroscopy
Pregabalin 300mg, Placebo oral tablet - Kidney Stone, Pain, Postoperative
Phase 2 / Phase 3CompletedUniversity of Missouri-Columbia1182020-06-012025-11-12
Mirabegron And Ureteral Stent-related Pain (MAP) Trial
Mirabegron 50 MG, Placebo oral tablet - Nephrolithiasis
Phase 3UnknownUnity Health Toronto1422020-02-032020-02-26
Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria
Reloxaliase, Placebo - Enteric Hyperoxaluria
Phase 3TerminatedAllena Pharmaceuticals922019-08-262022-06-10
Supine Percutaneous Nephrolithotomy
percutaneous nephrolithotomy (supine position), percutaneous nephrolithotomy ( prone position) - Renal Stone
Phase 2 / Phase 3CompletedAin Shams University702019-06-012022-07-14
Perioperative Pregabalin in Ureteroscopy: a Pilot
Pregabalin 300mg - Nephrolithiasis, Urolithiasis
Phase 3CompletedUniversity of Missouri-Columbia102019-04-012021-04-19
Pain Outcomes of Non-opioid vs. Opioid Analgesia for Kidney Stone Surgery.
Ketorolac Oral Tablet [Toradol], Acetaminophen, Oxycodone Acetaminophen - Nephrolithiasis
Phase 3CompletedMontefiore Medical Center1192018-07-272023-12-18
Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria
ALLN-177, Placebo - Enteric Hyperoxaluria
Phase 3CompletedAllena Pharmaceuticals1152018-05-212020-02-27
Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis
Lanthanum Carbonate - Secondary Hyperoxaluria, Nephrolithiasis
Phase 3CompletedUniversitair Ziekenhuis Brussel542017-08-182026-08-10
Efficacy of Liposomal Bupivacaine for Pain Control After Percutaneous Nephrostolithotomy
liposomal bupivicaine, Bupivacaine, Saline Solution - Renal Calculi, Postoperative Pain
Phase 3WithdrawnNorthwell Health2017-08-082017-08-28

Showing 20 of 35. Sign in to see all of them.

Narrower conditions

Kidney Calculi (20)  ·  Urolithiasis (4)  ·  Hypercalciuria (3)  ·  Hyperoxaluria (3)  ·  Nephrocalcinosis (3)  ·  Pain, Postoperative (3)  ·  Hypercalcemia (2)  ·  Acute Pain (1)  ·  Behavior, Addictive (1)  ·  Calcium Metabolism Disorders (1)  ·  Colic (1)  ·  Dent Disease (1)  ·  Glomerulonephritis (1)  ·  Granuloma, Foreign-Body (1)

Broader conditions

Female Urogenital Diseases (35)  ·  Female Urogenital Diseases and Pregnancy Complications (35)  ·  Male Urogenital Diseases (35)  ·  Kidney Diseases (34)  ·  Urogenital Diseases (34)  ·  Urologic Diseases (34)  ·  Urolithiasis (31)  ·  Pathological Conditions, Signs and Symptoms (26)  ·  Calculi (21)  ·  Pathological Conditions, Anatomical (21)  ·  Urinary Calculi (20)  ·  Pathologic Processes (7)  ·  Signs and Symptoms (7)  ·  Neurologic Manifestations (4)

Interventions

Tamsulosin (3)  ·  Bupivacaine (2)  ·  Furosemide (2)  ·  Hydrochlorothiazide (2)  ·  Morphine (2)  ·  Nephrolithotomy, Percutaneous (2)  ·  Pregabalin (2)  ·  alfuzosin (2)  ·  empagliflozin (2)  ·  oxalate decarboxylase (2)  ·  reloxaliase (2)  ·  silodosin (2)  ·  Acetaminophen (1)  ·  Adrenocorticotropic Hormone (1)  ·  Ampicillin (1)

Sponsors

Ain Shams University (3)  ·  Allena Pharmaceuticals (2)  ·  Insel Gruppe AG, University Hospital Bern (2)  ·  Northwell Health (2)  ·  University of Missouri-Columbia (2)  ·  Advance Shockwave Technology GmbH (1)  ·  Albany Medical College (1)  ·  Albert Einstein Healthcare Network (1)  ·  Assistance Publique - HĂ´pitaux de Paris (1)  ·  Brigham and Women's Hospital (1)  ·  Calcilytix Therapeutics, Inc., a BridgeBio company (1)  ·  Catalysis SL (1)  ·  Centre Hospitalier Departemental Vendee (1)  ·  Fredericia Hosptial (1)  ·  Hans Bahlmann (1)

Countries

United States (14)  ·  France (7)  ·  Canada (4)  ·  Denmark (4)  ·  Egypt (4)  ·  Italy (4)  ·  Germany (3)  ·  Switzerland (3)  ·  United Kingdom (3)  ·  Belgium (2)  ·  Brazil (2)  ·  Mexico (2)  ·  Spain (2)  ·  Australia (1)  ·  Austria (1)

Top investigators

Katie Murray, DO (2)  ·  Amr A Elsawy (1)  ·  Annamaria Kausz, MD MS (1)  ·  Brian K. Auge, M.D. (1)  ·  Charles Y. C. Pak (1)  ·  Christian Tielemans, MD, PhD (1)  ·  Daniel Fuster (1)  ·  Daniel Fuster, Prof MD (1)  ·  Dariush Irani, MD (1)  ·  David Clark, MD (1)  ·  David M Hoenig, md (1)  ·  Ehab Nour (1)

Results publications

PMID 10360498, PMID 18976849, PMID 24707884, PMID 27758119, PMID 28608192, PMID 29649900, PMID 30526528, PMID 30961854, PMID 31177306, PMID 31588790, PMID 36856614, PMID 37578113, PMID 38319254, PMID 38965611, PMID 39028573, PMID 40210001, PMID 41460253, PMID 42091145

NIH funding

2016 (1), 2018 (1), 2023 (1)